Acrodermatitis chronica atrophicans risk factors

Jump to navigation Jump to search

Acrodermatitis chronica atrophicans Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acrodermatitis chronica atrophicans from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acrodermatitis chronica atrophicans risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acrodermatitis chronica atrophicans risk factors

CDC on Acrodermatitis chronica atrophicans risk factors

Acrodermatitis chronica atrophicans risk factors in the news

Blogs on Acrodermatitis chronica atrophicans risk factors

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Acrodermatitis chronica atrophicans risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Overview

Common risk factors in the development of acrodermatitis chronica atrophicans include tick exposure, female gender and residents of northern, central and eastern Europe.

Risk Factors

Common Risk Factors

Common risk factors in the development of acrodermatitis chronica atrophicans include:[1][1][2][3][4]

  • Exposure to ticks
    • Frequent exposure to dogs, deers and other animals which may have ticks
    • Living near wooded areas or areas with high grass
  • Female gender
  • Residents of northern, central and eastern Europe


References

  1. 1.0 1.1 Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A; et al. (2011). "Lyme borreliosis: clinical case definitions for diagnosis and management in Europe". Clin Microbiol Infect. 17 (1): 69–79. doi:10.1111/j.1469-0691.2010.03175.x. PMID 20132258.
  2. Khalili M, Wong RJ (2018). "Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net". Dig Dis Sci. 63 (12): 3250–3252. doi:10.1007/s10620-018-5316-9. PMC 6436636. PMID 30311153.
  3. Asbrink E (1993). "Acrodermatitis chronica atrophicans". Clin Dermatol. 11 (3): 369–75. doi:10.1016/0738-081x(93)90092-q. PMID 8221518.
  4. Scott JD (2020). "Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada". Healthcare (Basel). 8 (2). doi:10.3390/healthcare8020157. PMC 7349802 Check |pmc= value (help). PMID 32512846 Check |pmid= value (help).

Template:WH Template:WS